Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 13:04
Evidence Synthesis
BIOGEN's Gross Margin accelerated to 100%, up from -62.06%.
The company's Marginal Operating Leverage moved from 33.6% to , decelerating. Daily Volume decreased by 0.698 shares, from 7226125 to . The Close Price remained flat at .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | -62.06 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -62.06 % | 33.6 | ▼ |
| REVENUE_GROWTH_YOY | -66.2 % | — | - |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 21,58,275 shares | 72,26,125 | ▼ |
| CLOSE_PRICE | 0.32 INR | 0.32 | - |